Fox Chase researchers uncover activation signal for Aurora-A oncogene

Discovery may lead to more potent drug combinations

2010-09-07

(Press-News.org) PHILADELPHIA, PA. (September 7, 2010)—Aurora-A kinase (AurA) is an enzyme that is hyperactive in many cancers and drives tumor cell proliferation. Several AurA inhibitors are currently being tested in clinical trials to see if they slow tumor growth. Now, researchers in the Developmental Therapeutics Program at Fox Chase Cancer Center have identified an activation signal for AurA. They report in the September 7 issue of Nature Communications that a quick increase in the calcium concentration in a cell rapidly triggers AurA kinase activity. The discovery may lead to drug combinations that had not previously been considered, and it may provide new insights into how the cell division cycle is timed.

"The results might suggest new ways to combine AurA inhibitors with other drugs to boost their activity," says Erica A. Golemis, Ph.D., Professor and senior author on the study. "Since we now know that AurA activation is controlled in part by calcium, we might combine an AurA inhibitor with drugs that target the calcium machinery in the cell."

AurA is best known for its role in pushing cells through cell division, but in 2007, Golemis was one of the first to report that the protein also functions in non-dividing cells, controlling a process important for cancerous transformation. The signals that turn on AurA kinase activity, however, are not well understood in either dividing or non-dividing cells. Putting together hints from studies in mammalian cells, frog oocytes, and single-celled algae, Golemis's team hypothesized that calcium could be a missing trigger for AurA signaling.

When they tested the idea in human kidney cells, they found that an increase in the amount of free calcium in the cell cytoplasm turned on AurA kinase activity. Together with Roland L. Dunbrack, PhD, a colleague in the Developmental Therapeutics Program, the investigators found that calcium first binds to a small protein called calmodulin, and then together the calcium-calmodulin complex bind to AurA directly.

"Our data might partly explain why AurA is active in tumors," Golemis says. "Tumors frequently have altered calcium signaling, and that altered signaling could be contributing to the oncogenic activity of the kinase."

This work suggests previously unexpected drug combinations, such as targeting AurA and calmodulin together, may have value in improving treatment of cancers with activated AurA. Golemis also thinks the data may offer new insight into the rapid activation of AurA that helps push the cell into mitosis. Once bound to the calcium-calmodulin complex, the AurA protein may change shape enough so that it can bind with other interacting proteins. Thus the calcium-calmodulin binding would act as a quick initial trigger for AurA activity, while the binding to other interacting proteins would allow AurA to have long-term activity.

INFORMATION: Olga V. Plotnikova of Fox Chase is lead author on the paper. Elena N. Pugacheva from West Virginia University in Morgantown is a co-author. The work is supported in part by the Fox Chase Cancer Center Keystone in Kidney Cancer, based on the specific relevance of AurA signaling to factors impacting kidney pathology.

Fox Chase Cancer Center is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at www.fccc.org or call 1-888-FOX CHASE (1-888-369-2427).

ELSE PRESS RELEASES FROM THIS DATE:

New method for infrared remote sensing to analyze traffic pollution

2010-09-07

The methodology, which has been used in this research in collaboration with the Universidad Europea de Madrid, is based on the Open-Path FTIR technique which takes advantage of specific properties of gases in order to detect them: they absorb radiation only in certain wave lengths which are always the same and particular to each gas. Many gases have absorption lines or bands in the infrared, for which this area of the electromagnetic spectrum is very useful for the remote detection of gases, according to the authors of this research from the UC3M Department of Physics. ...

First Irish genome sequenced

2010-09-07

The first entire genome of an Irish individual has been sequenced. The sequence is reported in BioMed Central's open access journal, Genome Biology and provides insight into the evolutionary history of this distinct lineage. Led by Professor Brendan Loftus, the research team from UCD Conway Institute used data from a previous genotyping study to select a suitable Irish male representative for sequencing. Then, using pair- and single-ended Illumina short read sequencing, one of the next generation sequencing approaches, the team created 9 DNA sequence libraries, which ...

GOCE gravity mission back in action

2010-09-07

ESA's GOCE gravity mission has recovered from a glitch that prevented the satellite from sending its flow of scientific data to the ground. News of the recovery comes earlier than expected, thanks to the fervent efforts of a team of experts. The recovery follows a serious communications malfunction on 8 July, when the Gravity field and steady-state Ocean Circulation Explorer (GOCE) satellite suddenly failed to downlink scientific data to its receiving stations. Extensive investigations by experts from ESA and industry revealed that the issue was almost certainly related ...

What can a New Zealand reptile tell us about false teeth?

2010-09-07

Using a moving 3D computer model based on the skull and teeth of a New Zealand reptile called tuatara, a BBSRC-funded team from the University of Hull, University College London and the Hull York Medical School has revealed how damage to dental implants and jaw joints may be prevented by sophisticated interplay between our jaws, muscles and brain. This research will appear in a future edition of the Journal of Biomechanics. The tuatara is a lizard-like reptile that has iconic status in its homeland of New Zealand because its ancestors were widespread at the time of the ...

Is hand washing enough to stop the spread of disease?

2010-09-07

Not drying your hands thoroughly after washing them, could increase the spread of bacteria and rubbing your hands whilst using a conventional electric hand dryer could be a contributing factor. Frequently people give up drying their hands and wipe them on their clothes instead, but hand-hygiene is a key part of infection control and drying hands after washing is a very important part of the process. A study by researchers at the University of Bradford and published today in the Journal of Applied Microbiology looked at different methods of hand drying, and their effect ...

Unrelated kidney donor study shows age and obesity increase complications

2010-09-07

Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care. Researchers from Iran studied 360 recipients who had received kidneys from unrelated donors to discover what factors increased the risk of TRAS, where the renal arteries narrow, impeding blood flow to the kidney. They found that having had a previous transplant, elevated triglyceride (fatty molecule) levels, cytomegalovirus (CMV) infection ...

Multivitamin use doesn't impact colon cancer outcomes

2010-09-07

BOSTON--Patients with colon cancer who used multivitamins during and after being treated with post-surgical chemotherapy did not reduce the risk of the cancer returning or their dying from it, according to researchers at Dana-Farber Cancer Institute. In a study of patients with stage III colon cancer – characterized as cancer in the large bowel area with some cancer cells in a few nearby lymph nodes -- the researchers found that while multivitamin use had no beneficial effect on patients' outcomes, it also did not have a detrimental effect. The findings are reported online ...

The rare aging disease, Progeria, linked to aging in the general population

2010-09-07

BOSTON, MA (September 7, 2010) – Progeria, also known as Hutchinson-Gilford Progeria Syndrome (HGPS), is a rare, fatal genetic disease characterized by an appearance of accelerated aging in children. All children with Progeria die of the same heart disease that affects millions of normal aging adults (atherosclerosis), but instead of occurring at 60 or 70 years of age, these children may suffer heart attacks and strokes even before age 10, and the average age of death is 13 years. Finding treatments and a cure for Progeria may provide clues to preventing or treating heart ...

Having a male co-twin improves mental rotation performance in females

2010-09-07

Having a sibling, especially a twin, impacts your life. Your twin may be your best friend or your biggest rival, but throughout life you influence each other. However, a recent study published in Psychological Science, a journal of the Association for Psychological Science, shows that having an opposite-sex twin may impact you even before you are born: females with a male co-twin score higher on mental rotation task than females with a female co-twin. Males, as young as three months of age, outperform females on mental rotation tasks, tests that require rotation of three ...

Can we spot volcanoes on alien worlds? Astronomers say yes

2010-09-07

Volcanoes display the awesome power of Nature like few other events. Earlier this year, ash from an Icelandic volcano disrupted air travel throughout much of northern Europe. Yet this recent eruption pales next to the fury of Jupiter's moon Io, the most volcanic body in our solar system. Now that astronomers are finding rocky worlds orbiting distant stars, they're asking the next logical questions: Do any of those worlds have volcanoes? And if so, could we detect them? Work by theorists at the Harvard-Smithsonian Center for Astrophysics suggests that the answer to the ...

Fox Chase researchers uncover activation signal for Aurora-A oncogene

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: